NCT06725641View on ClinicalTrials.gov

Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 24, 2024

Primary Completion Date

October 22, 2024

Study Completion Date

October 26, 2024

Conditions
Asthma
Interventions
DRUG

Test preparation：Methylcholine chloroacetate for inhalation

Cholinergic agonists

DRUG

Reference preparation：Methylcholine chloroacetate for inhalation（Provocholine）

Cholinergic agonists

Trial Locations (1)

100029

China-japan Friendship Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY

lead

China-Japan Friendship Hospital

OTHER